DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report second-quarter results before trading begins on April 21, 2010. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

• At Covidien’s website: http://investor.covidien.com
• By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-713-8562. For participants outside the U.S., the dial-in number is 617-597-5310. The access code for all callers is 34024241.
• Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on April 21, 2010, and ending at 5:00 p.m. on April 28, 2010. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 73962044.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.